Tuesday, September 3, 2013

Esperion's drug lowers blood fat in mid-stage study

(Reuters) - Esperion Therapeutics Inc said its drug reduced levels of bad blood fat in a mid-stage trial among patients with high levels of cholesterol, when added to a standard of care treatment.






No comments:

Post a Comment

Subscribe Now: Feed Icon